Madrigal Pharmaceuticals (MDGL) Other Gross PP&E Adjustments (2019 - 2025)
Madrigal Pharmaceuticals (MDGL) has disclosed Other Gross PP&E Adjustments for 12 consecutive years, with -$26.9 million as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments fell 43.41% to -$26.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$26.9 million, a 43.41% decrease, with the full-year FY2025 number at -$26.9 million, down 43.41% from a year prior.
- Other Gross PP&E Adjustments was -$26.9 million for Q4 2025 at Madrigal Pharmaceuticals, down from -$5.4 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$411000.0 in Q2 2023 to a low of -$35.7 million in Q4 2023.
- A 5-year average of -$8.1 million and a median of -$1.7 million in 2023 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 61.12% in 2023, then crashed 302.61% in 2025.
- Madrigal Pharmaceuticals' Other Gross PP&E Adjustments stood at -$25.1 million in 2021, then decreased by 10.73% to -$27.8 million in 2022, then fell by 28.25% to -$35.7 million in 2023, then skyrocketed by 47.48% to -$18.7 million in 2024, then plummeted by 43.41% to -$26.9 million in 2025.
- Per Business Quant, the three most recent readings for MDGL's Other Gross PP&E Adjustments are -$26.9 million (Q4 2025), -$5.4 million (Q3 2025), and -$5.9 million (Q2 2025).